Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

NCT04047706 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: IDO1 Inhibitor BMS-986205 25mg
DRUG: Nivolumab
RADIATION: Radiation Therapy
DRUG: Temozolomide
DRUG: IDO1 Inhibitor BMS-986205 50 mg
DRUG: IDO1 Inhibitor BMS-986205 100 mg

Sponsor

Northwestern University

Collaborators

[object Object]